Antimicrobial peptides and gut microbiota in homeostasis and pathology
- PMID: 24039130
- PMCID: PMC3799574
- DOI: 10.1002/emmm.201201773
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Abstract
We survive because we adapted to a world of microorganisms. All our epithelial surfaces participate in keeping up an effective barrier against microbes while not initiating ongoing inflammatory processes and risking collateral damage to the host. Major players in this scenario are antimicrobial peptides (AMPs). Such broad-spectrum innate antibiotics are in part produced by specialized cells but also widely sourced from all epithelia as well as circulating inflammatory cells. AMPs belong to an ancient defense system found in all organisms and participated in a preservative co-evolution with a complex microbiome. Particularly interesting interactions between host barrier and microbiota can be found in the gut. The intestinal cell lining not only has to maintain a tightly regulated homeostasis during its high-throughput regeneration, but also a balanced relationship towards an extreme number of mutualistic or commensal inhabitants. Recent research suggests that advancing our understanding of the circumstances of such balanced and sometimes imbalanced interactions between gut microbiota and host AMPs should have therapeutic implications for different intestinal disorders.
Keywords: antimicrobial peptides; defensin; epithelial differentiation; intestinal homeostasis; microbiota.
© 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.
Figures
Similar articles
-
Microbiota and mucosal defense in IBD: an update.Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):963-976. doi: 10.1080/17474124.2019.1671822. Epub 2019 Oct 11. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31603356 Review.
-
Inflammatory bowel disease: an impaired barrier disease.Langenbecks Arch Surg. 2013 Jan;398(1):1-12. doi: 10.1007/s00423-012-1030-9. Epub 2012 Nov 18. Langenbecks Arch Surg. 2013. PMID: 23160753 Review.
-
Interplay between gut microbiota and antimicrobial peptides.Anim Nutr. 2020 Dec;6(4):389-396. doi: 10.1016/j.aninu.2020.09.002. Epub 2020 Oct 8. Anim Nutr. 2020. PMID: 33364454 Free PMC article. Review.
-
Balancing Act of the Intestinal Antimicrobial Proteins on Gut Microbiota and Health.J Microbiol. 2024 Mar;62(3):167-179. doi: 10.1007/s12275-024-00122-3. Epub 2024 Apr 17. J Microbiol. 2024. PMID: 38630349 Free PMC article. Review.
-
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.J Crohns Colitis. 2016 Aug;10(8):943-52. doi: 10.1093/ecco-jcc/jjw051. Epub 2016 Feb 19. J Crohns Colitis. 2016. PMID: 26896085
Cited by
-
Location is important: differentiation between ileal and colonic Crohn's disease.Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):544-558. doi: 10.1038/s41575-021-00424-6. Epub 2021 Mar 12. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33712743 Review.
-
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.Arch Med Res. 2021 Aug;52(6):582-594. doi: 10.1016/j.arcmed.2021.03.002. Epub 2021 Mar 19. Arch Med Res. 2021. PMID: 33785208 Free PMC article. Review.
-
Ascarosides and Symbiotic Bacteria of Entomopathogenic Nematodes Regulate Host Immune Response in Galleria mellonella Larvae.Insects. 2024 Jul 9;15(7):514. doi: 10.3390/insects15070514. Insects. 2024. PMID: 39057246 Free PMC article.
-
Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe?Pathophysiology. 2022 Sep 1;29(3):507-536. doi: 10.3390/pathophysiology29030041. Pathophysiology. 2022. PMID: 36136068 Free PMC article. Review.
-
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.Sci Rep. 2024 Jul 4;14(1):15460. doi: 10.1038/s41598-024-65061-w. Sci Rep. 2024. PMID: 38965287 Free PMC article.
References
-
- Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol. Cell. 2007;27:53–66. - PubMed
-
- Andreu P, Colnot S, Godard C, Gad S, Chafey P, Niwa-Kawakita M, Laurent-Puig P, Kahn A, Robine S, Perret C, et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development. 2005;132:1443–1451. - PubMed
-
- Andreu P, Peignon G, Slomianny C, Taketo MM, Colnot S, Robine S, Lamarque D, Laurent-Puig P, Perret C, Romagnolo B. A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation. Dev Biol. 2008;324:288–296. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
